Goldman Sachs and UBS have emerged as the leading mergers and acquisitions (M&A) financial advisers in South America for 2024, in terms of deal value and volume, respectively, according to the latest league table from GlobalData, a data and analytics firm.

UBS analyst Brennan Hawken raised the firm’s price target on Goldman Sachs (GS) to $640 from $610 and keeps a Neutral rating on the shares. The

BMO Capital Markets forecasts the S&P 500 will reach 6,700, reflecting a gain of 13.2%. Chief investment strategist Brian Belski said he and his team "remain resolutely bullish," but expect "performance and fundamentals will more closely match the historical norms -- namely, in the high-single digit/low-double-digit percentage range in 2025."

Analyst Ratings: In the last 15 days, Oppenheimer lowered Goldman Sachs stock price forecast from $677 to $639, UBS downgraded the stock to a Neutral rating with a price forecast of $610 ...

For Q3FY25, HUL reported a net profit of Rs 3,001 crore, exceeding estimates, although profit before exceptional items (PAT bei) remained flat. Sales grew modestly by 2% YoY to Rs 15,195 crore, while underlying volume growth (UVG) remained unchanged.

Mainland-listed stocks are likely to be higher at the end of 2025 thanks to improved corporate earnings and policy support from Beijing, UBS Group said, despite a shaky start to the year.

Goldman Sachs and UBS have emerged as the leading mergers and acquisitions (M&A) financial advisers in South America for 2024, in terms of deal value and volume, respectively, according to the ...

Jefferies analyst Brian Tanquilut upgraded Option Care Health (NASDAQ:OPCH) stock rating from Hold to Buy, setting a new price target at $35.00, an increase from the previous target of $26.00. The company,

Goldman Sachs CEO David Solomon said on Wednesday it was important for the U.S. and China, the world's two largest economic superpowers, to improve their bilateral ties.

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot

TJX Companies Inc (TJX) stock saw a modest uptick, ending the day at $121.85 which represents a slight increase of $0.47 or 0.39% from the prior close of $121.38. The stock opened at $122.58 and touched a low of $121.